Art

J-GLOBAL ID：201702240625084863   Reference number：17A0389846

Management of Kidney Disease on Cancer Chemotherapy with Other Drugs than Platinum Agents

腎障害時のがん薬物療法 がん薬物療法と腎障害-白金製剤以外の薬剤-

Author (1)： SHIMODAIRA HIDEKI (東北大 加齢医研 臨床腫瘍学分野)
Material： 癌と化学療法  (Japanese Journal of Cancer and Chemotherapy)
Volume： 44  Issue： 3  Page： 204-210  Publication year： Mar. 15, 2017 
JST Material Number： Z0938A  ISSN： 0385-0684  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *tumor ,...
Semi thesaurus term： Bisphosphonate

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0389846&from=J-GLOBAL&jstjournalNo=Z0938A") }}

JST classification (2)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Urogenital diseases  (GM03000L)

Substance index (1)： Methotrexate

Reference (29)：

• Howard SC, McCormick J, Pui CH, et al: Preventing and managing toxicities of high-dose methotrexate. Oncologist 21 (12): 1471-1482, 2016.
• Goldin A, Venditti JM, Kline I, et al: Eradication of leukaemic cells (L1210) by methotrexate and methotrexate plus citrovorum factor. Nature 212 (5070) : 1548- 1550, 1966.
• Jaffe N: Recent advances in the chemotherapy of metastatic osteogenic sarcoma. Cancer 30 (6): 1627-1631, 1972.
• Rosen G, Marcove RC, Caparros B, et al: Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery. Cancer 43 (6): 2163-2177, 1979.
• Rosen G, Caparros B, Huvos AG, et al: Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49 (6) :1221-1230, 1982.

Terms in the title (4)： 腎障害 ,  がん薬物療法 ,  白金製剤 ,  薬剤